New Drug Application to be submitted mid-year with approval (hopefully) by December 2022/January 2023. That is 11-12months away.
Rest of World commercial partners could be announced any day.
$3 share price value for Trofinetide alone is crazy. Surely if drug is approved the share price goes to $10/minimum. Risk vs reward for an 11month wait......
Looking forward to this quarterly (released tomorrow or Monday) to give an update on the IND applications for planned phase 2 trials for NNZ-2591.
New Drug Application to be submitted mid-year with approval...
-
- There are more pages in this discussion • 10,930 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.69 |
Change
-0.230(1.65%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.94 | $13.96 | $13.50 | $3.577M | 261.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 45 | $13.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.69 | 1896 | 15 |
View Market Depth
| Last trade - 14.30pm 06/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |